ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,431.60
      -0.04%
      US Tech 100
      19,168.00
      0.52%
      Dow Jones
      38,589.16
      -0.15%
      Brent Oil
      82.275
      0.00%
      Bitcoin
      66,062.56
      0.09%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. BeiGene Ltd (BGNE)

      7. BeiGene Ltd (BGNE) News

      BGNE

      BeiGene (BGNE)

      BeiGene Ltd
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:BGNE
      DateTimeSourceHeadlineSymbolCompany
      06/14/20246:00AMBusiness WireBeiGene to Present New Data from SEQUOIA Study Evaluating BRUKINSA® plus Venetoclax in High-Risk First-Line CLL/SLL at EHA2024NASDAQ:BGNEBeiGene Ltd
      06/13/20247:41PMBusiness WireBeiGene and NewBridge Pharmaceuticals FZ LLC Mutually Agree to Conclude BRUKINSA® (Zanubrutinib) Partnership in the Middle East and Africa (MENA) RegionNASDAQ:BGNEBeiGene Ltd
      06/07/20245:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BGNEBeiGene Ltd
      06/07/20245:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BGNEBeiGene Ltd
      06/07/20245:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BGNEBeiGene Ltd
      06/07/20245:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BGNEBeiGene Ltd
      06/07/20245:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BGNEBeiGene Ltd
      06/07/20244:58PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BGNEBeiGene Ltd
      06/07/20244:57PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BGNEBeiGene Ltd
      06/07/20244:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BGNEBeiGene Ltd
      06/07/20244:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BGNEBeiGene Ltd
      06/07/20244:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BGNEBeiGene Ltd
      06/07/20244:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BGNEBeiGene Ltd
      06/05/20245:23PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:BGNEBeiGene Ltd
      06/05/20244:35PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BGNEBeiGene Ltd
      06/04/20246:01AMBusiness WireBeiGene to Present at the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:BGNEBeiGene Ltd
      05/28/20248:00AMGlobeNewswire Inc.BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS™ First in Human StudyNASDAQ:BGNEBeiGene Ltd
      05/24/20246:00AMBusiness WireBRUKINSA® Data at ASCO Underscore Differentiated Clinical Profile for Treatment of CLL and SLLNASDAQ:BGNEBeiGene Ltd
      05/15/20246:10PMBusiness WireEHA2024: BeiGene präsentiert neues Hämatologie-Portfolio und Pipeline-DatenNASDAQ:BGNEBeiGene Ltd
      05/15/20245:50PMBusiness WireBeiGene présente de nouvelles données de portefeuille et de pipeline d'hématologie à l'EHA2024NASDAQ:BGNEBeiGene Ltd
      05/14/20244:01PMBusiness WireBeiGene Highlights New Hematology Portfolio and Pipeline Data at EHA2024NASDAQ:BGNEBeiGene Ltd
      05/09/20243:03PMBusiness WireBeiGene meldet Finanzergebnisse für das erste Quartal 2024 und aktuelle GeschäftsentwicklungenNASDAQ:BGNEBeiGene Ltd
      05/09/20249:38AMBusiness Wireベイジーン、2024年第1四半期決算および事業に関する最新情報を発表NASDAQ:BGNEBeiGene Ltd
      05/08/20249:02PMBusiness WireBeiGene公布2024年第一季財務業績和最新業務情況NASDAQ:BGNEBeiGene Ltd
      05/08/20247:03PMBusiness WireBeiGene présente ses résultats financiers du premier trimestre 2024 et ses dernières nouvelles commercialesNASDAQ:BGNEBeiGene Ltd
      05/08/20246:00AMBusiness WireBeiGene Reports First Quarter 2024 Financial Results and Business UpdatesNASDAQ:BGNEBeiGene Ltd
      04/26/202410:34AMBusiness WireBeiGene Demonstrates Global Progress in 2023 Responsible Business & Sustainability ReportNASDAQ:BGNEBeiGene Ltd
      04/25/20247:11AMBusiness WireGlobaler Onkologie-Innovator BeiGene präsentiert auf der ASCO-Jahrestagung 2024 neue Daten aus dem gesamten Portfolio für Hämatologie und solide TumoreNASDAQ:BGNEBeiGene Ltd
      04/25/20247:10AMBusiness WireBeiGene, innovateur mondial en oncologie, présente de nouvelles données sur l’ensemble de son portefeuille en hématologie et en tumeurs solides lors de la réunion annuelle de l’ASCO 2024NASDAQ:BGNEBeiGene Ltd
      04/24/20244:01PMBusiness WireGlobal Oncology Innovator BeiGene Highlights New Data across Hematology and Solid Tumor Portfolio at 2024 ASCO Annual MeetingNASDAQ:BGNEBeiGene Ltd
       Showing the most relevant articles for your search:NASDAQ:BGNE